Lycia Therapeutics, Inc. LYCA
33.15 USD +1.85 (+5.91%)
Nov 11, 2026, 11:47 AM EST
31.50 Day range 33.56
22.19 52-week range 36.49
- YTD
- +10.50%
- 1 year
- +10.50%
LYCA revenue history
Revenue is income from the company’s ordinary business activities.
6,741,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 6,741,000 | -8,195,000 | -54.87% |
| FY 2024 | 2024-12-31 | 14,936,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-10-25T06:00:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.